Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1962 1
1965 2
1971 1
1972 2
1975 2
1976 2
1977 1
1978 2
1979 1
1981 1
1983 1
1985 3
1986 3
1987 2
1988 1
1989 8
1990 6
1991 2
1992 8
1993 3
1994 3
1995 2
1996 4
1997 1
1998 1
2000 10
2001 2
2002 2
2003 1
2004 6
2005 7
2006 3
2007 4
2008 6
2009 10
2010 10
2011 9
2012 7
2013 20
2014 22
2015 26
2016 18
2017 19
2018 20
2019 20
2020 26
2021 30
2022 27
2023 19
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.
Whitehill GD, Joy J, Marino FE, Krause RJ, Mallick S, Courtney HM, Park K, Carey JW, Hoh R, Hartig H, Pae V, Sarvadhavabhatla S, Donaire MSB, Deeks SG, Lynch RM, Lee SA, Bar KJ. Whitehill GD, et al. Among authors: joy j. J Clin Invest. 2024 Apr 23:e176673. doi: 10.1172/JCI176673. Online ahead of print. J Clin Invest. 2024. PMID: 38652564 Free article.
What's ahead for complete responders following NACT?
Ram B, Verma S, Thakur S, Subash A, Rao VUS, Joy J. Ram B, et al. Among authors: joy j. Oral Oncol. 2024 May;152:106776. doi: 10.1016/j.oraloncology.2024.106776. Epub 2024 Mar 29. Oral Oncol. 2024. PMID: 38554596 No abstract available.
The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K, Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A, Gange S, Aouizerat B, Kuniholm MH, Kassaye S, Mullins JI, Goldstein H, Joy JB, Anastos K, Brumme ZL; MACS/WIHS combined cohort study (MWCSS). Shahid A, et al. Among authors: joy jb. J Virol. 2024 Feb 20;98(2):e0165523. doi: 10.1128/jvi.01655-23. Epub 2024 Jan 12. J Virol. 2024. PMID: 38214547 Free PMC article.
367 results